Viogen Semaglutide: What the Name Means and What UK Patients Should Know

What exactly is Viogen semaglutide, and why are people searching for it?

Viogen Pharmaceuticals is a compounding company that produces semaglutide in various forms (including injectable vials and oral formulations) and markets them largely through wellness clinics and direct-to-consumer channels, mainly in the United States. The name has spread to UK search results because people researching semaglutide weight-loss treatment encounter it in forums, social media posts, and overseas clinic websites.

Compounded semaglutide means the active ingredient is prepared by a compounding pharmacy rather than manufactured by the original pharmaceutical company (Novo Nordisk) to a licensed specification. In the US, compounding of semaglutide was temporarily permitted by the FDA during a period of official shortage. That regulatory context does not apply in the UK. The MHRA licenses individual medicines; compounded versions of those medicines are not automatically covered by that authorisation, and selling them for weight management to UK patients sits outside the licensed supply chain.

The short answer, then, to why this search term exists: people have heard about semaglutide working for weight loss, found the Viogen name attached to it somewhere online, and want to know whether they can access it. The honest answer is that for UK patients, the licensed route is different, and it matters which route you take. You can read more about what licensed semaglutide treatment looks like on our semaglutide overview page.

Is Viogen semaglutide available or legal to use in the UK?

Viogen's compounded semaglutide products are not MHRA-authorised medicines. That means they do not have a UK marketing authorisation for weight management (or any other indication). A GPhC-registered pharmacy in the UK cannot legally dispense an unlicensed product for a use that has a licensed alternative available, and Wegovy (semaglutide 2.4mg, and now up to 7.2mg) is a licensed alternative.

The MHRA has been explicit about this risk. Its public guidance on GLP-1 medicines for weight loss warns that unlicensed semaglutide products may be of unknown quality, strength or purity. Enforcement actions through 2025 seized approximately 20 million doses of illegally traded weight-loss medicines, worth around £45 million, a figure that reflects how large and dangerous the unlicensed market has become. You can report any suspect seller directly through the MHRA Yellow Card scheme.

One misconception worth gently setting aside: the idea that compounded semaglutide is simply a cheaper version of the same thing. It isn't. The manufacturing standards, excipients, concentration accuracy and sterility testing that apply to Wegovy do not automatically apply to compounded products. A lower price can reflect a lower standard, not a better deal. For more detail on how the licensed UK supply chain works, the Viogen Pharmaceuticals semaglutide page covers the supplier context specifically.

What is the licensed semaglutide option for weight management in the UK?

Wegovy is the MHRA-authorised brand of semaglutide for weight management in the UK, produced by Novo Nordisk. It is a once-weekly subcutaneous injection, starting at 0.25mg and titrated by a prescriber over several months, with our semaglutide 1mg dosing information page covering what to expect at the earlier stages of that journey. The NHS semaglutide medicines page gives a clear overview of how it works and what to expect.

Clinical trial data (the STEP 1 trial, published in the New England Journal of Medicine) showed an average body-weight reduction of around 15% over 68 weeks at the 2.4mg dose, alongside a reduced-calorie diet and increased activity. Those are meaningful results for many people, but they come from a monitored, prescribed, dose-titrated programme, not from a vial ordered online.

As of June 2026, there is also an oral option: Wegovy tablets, the first oral GLP-1 medicine licensed in the UK for weight management, and if you want to understand what the higher end of treatment looks like before committing, our semaglutide 2mg dosing page walks through that stage in detail. If you're curious about whether an injection or a tablet suits you better, that is exactly the kind of question a prescriber can work through with you. The Wegovy tablet page has full details on the oral route.

Eligibility for private treatment follows the licensed criteria: adults with a BMI of 30 or above, or 27 or above alongside a weight-related health condition such as high blood pressure or type 2 diabetes. BMI alone is not the whole picture; the prescriber reviews your full health history. Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance.

How does a legitimate UK prescription for semaglutide actually work?

Getting semaglutide through a regulated UK pharmacy starts with a clinical consultation. At nume, that means a free consultation reviewed the same day by a GPhC-registered Independent Prescriber, a real clinician reading your answers, not automated software making the call. Identity is verified by photo ID, and weight is confirmed on a live video check. Both steps matter: they protect you and uphold the prescribing standards the MHRA expects.

You can verify any online pharmacy on the GPhC register before you hand over a single piece of personal information. Our registration number is 9012878, verifiable directly at pharmacyregulation.org. If a seller cannot point you to a GPhC-registered pharmacy, that is a clear signal to look elsewhere.

Once approved as clinically suitable, orders placed before 12pm on a working day are dispatched the same day and delivered free the next working day by DPD, in plain unbranded packaging. Every repeat order is reviewed again before dispatch, there are no automatic renewals. If you'd like to explore whether semaglutide treatment is right for you, our free consultation is the place to start. The FAQs page also covers common questions about the process.